Accelerated growth of established tumor tissue in the mammary tumor transplant model (Fig. 2E) suggests that IL-27 signals can contribute to anti-tumor responses during carcinoma growth, as well as influencing tumor initiation. This evidence concerns the gene IL27 and breast cancer.